SOLV
Solventum Corp.NYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$13.31B
P/E Ratio
9.40
EPS
$8.17
Beta
0.66
52W High
$88.20
52W Low
$62.38
50-Day MA
$68.75
200-Day MA
$73.90
Dividend Yield
—
Profit Margin
17.30%
Forward P/E
11.72
PEG Ratio
1.22
About Solventum Corp.
Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.
Fundamentals
| Revenue (TTM) | $8.26B |
| Gross Profit (TTM) | $4.43B |
| EBITDA | $1.12B |
| Operating Margin | 5.58% |
| Return on Equity | 34.80% |
| Return on Assets | 2.75% |
| Revenue/Share (TTM) | $47.42 |
| Book Value | $29.10 |
| Price-to-Book | 2.68 |
| Price-to-Sales (TTM) | 1.61 |
| EV/Revenue | 2.183 |
| EV/EBITDA | 7.24 |
| Quarterly Earnings Growth (YoY) | -91.00% |
| Quarterly Revenue Growth (YoY) | -3.00% |
| Shares Outstanding | $173.18M |
| Float | $147.07M |
| % Insiders | 15.07% |
| % Institutions | 76.46% |
Historical Volatility
HV 10-Day
20.67%
HV 20-Day
26.15%
HV 30-Day
24.70%
HV 60-Day
28.10%
HV Rank
33.3%
Volatility is currently contracting
Analyst Ratings
Consensus ($82.08 target)
1
Strong Buy5
Buy5
Hold2
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026